Avoro Capital Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,275,000	Closed	-$55.1M	–	41
2022 Q1	$55.1M	Buy	2,275,000 +75,000	+3%	+$1.81M	1.01%	19
2021 Q4	$51.3M	Hold	2,200,000	–	–	0.87%	19
2021 Q3	$36.5M	Sell	2,200,000 -241,658	-10%	-$4.66M	0.57%	27
2021 Q2	$59.6M	Sell	2,441,658 -58,342	-2%	-$1.32M	1.04%	22
2021 Q1	$64.5M	Buy	2,500,000 +550,000	+28%	+$24.2M	1.11%	20
2020 Q4	$104M	Buy	+1,950,000	New	+$96.8M	1.8%	16
2020 Q2	–	Sell	-145,000	Closed	-$6.13M	–	46
2020 Q1	$6.13M	Buy	+145,000	New	+$5.97M	0.21%	40
2019 Q4	–	Sell	-887,500	Closed	-$31.9M	–	32
2019 Q3	$31.9M	Sell	887,500 -437,500	-33%	-$13.3M	1.33%	18
2019 Q2	$35.4M	Hold	1,325,000	–	–	1.23%	19
2019 Q1	$35.6M	Buy	+1,325,000	New	+$30.9M	1.54%	19
2018 Q4	–	Sell	-100,000	Closed	-$2.08M	–	36
2018 Q3	$2.08M	Buy	+100,000	New	+$1.57M	0.1%	39
2018 Q2	–	Sell	-317,100	Closed	-$7.13M	–	44
2018 Q1	$7.13M	Buy	+317,100	New	+$8.78M	0.34%	36
2017 Q3	–	Sell	-614,200	Closed	-$17.1M	–	44
2017 Q2	$17.1M	Sell	614,200 -1,015,800	-62%	-$30.3M	2.17%	14
2017 Q1	$56M	Buy	1,630,000 +143,540	+10%	+$5.07M	7.17%	4
2016 Q4	$42.9M	Buy	1,486,460 +693,961	+88%	+$18.4M	8.68%	1
2016 Q3	$25.2M	Buy	792,499 +462,999	+141%	+$15.7M	4.48%	8
2016 Q2	$10.7M	Buy	+329,500	New	+$11M	2.4%	15
2015 Q4	–	Sell	-581,900	Closed	-$19.2M	–	30
2015 Q3	$19.2M	Buy	581,900 +86,900	+18%	+$3.62M	5.09%	6
2015 Q2	$20.7M	Buy	+495,000	New	+$19.2M	5.72%	6